论文部分内容阅读
近年来,手术及放射、化学疗法在食管癌治疗方面取得了一定的进步,然而对食管癌患者并没有带来长期生存率的明显增高。分子靶向治疗在食管癌的应用逐渐受到越来越多的关注。目前,已有众多Ⅰ/Ⅱ期临床试验用于评估食管癌分子靶向治疗疗效。
In recent years, surgery and radiation, chemotherapy has made some progress in the treatment of esophageal cancer, however, patients with esophageal cancer did not bring significant increase in long-term survival. Molecular targeted therapy in esophageal cancer is gradually receiving more and more attention. At present, many Phase I / II clinical trials have been used to evaluate the molecular targeted therapy of esophageal cancer.